— Gilead Sciences (NYSE: GILD) reported third-quarter 2019 earnings of $1.75 per share, vs. $1.74 per share expected.
— Total revenue remained flat at $5.60 billion, vs. $5.61 billion expected. Total product sales were flat at 5.5 billion.
— Narrowed full year 2019 guidance on sales to $21.8-22.1 billion, from earlier esimtate of $21.6-22.1 billion.
— GILD shares have been trading sideways since the beginning of this year. The stock has so far declined 3% this year.
Get access to timely and accurate verbatim transcripts that are published within hours of the event.
Most Popular
Verizon Communications (VZ) Q1 2024 Earnings: Key financials and quarterly highlights
Verizon Communications Inc. (NYSE: VZ) reported first quarter 2024 earnings results today. Total operating revenue was $33 billion, up 0.2% from the same period last year. Net income attributable to
NextTrip stands out as one of the most descriptive names in travel sector: CEO
NextTrip, Inc. (NASDAQ: NTRP) is a technology-driven travel agency that offers travel booking and interactive travel media solutions. The online platform allows travelers to book accommodation and transportation services including
What to look for when American Airlines (AAL) reports Q1 2024 earnings results
Shares of American Airlines Group Inc. (NASDAQ: AAL) rose 1% on Friday. The stock has gained over 3% over the past three months. The airline is scheduled to report its first